celiprolol has been researched along with Asthma in 25 studies
Celiprolol: A cardioselective beta-1 adrenergic antagonist that has intrinsic sympathomimetic activity. It is used in the management of ANGINA PECTORIS and HYPERTENSION.
Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).
| Excerpt | Relevance | Reference |
|---|---|---|
| " In two, randomized, placebo-controlled, 5-way crossover trials, the pulmonary effects of celiprolol 200 and 400 mg, propranolol 40 mg and atenolol 100 mg were compared in 34 asthmatic patients." | 9.06 | Celiprolol, atenolol and propranolol: a comparison of pulmonary effects in asthmatic patients. ( Applin, WJ; Brown, R; Caruso, FS; Doshan, HD; Rosenthal, RR; Slutsky, A, 1986) |
| "Sixteen normotensive asthmatic patients received single doses of 400 and 600 mg of celiprolol and 100 mg of atenolol in this placebo-controlled, double-blind crossover study." | 9.06 | Effects of high doses of celiprolol in asthmatic patients. ( Applin, WJ; Brown, R; Caruso, FS; Doshan, HD; Kapoor, M, 1986) |
| "The bronchopulmonary effects of celiprolol were studied in 12 male asthmatic patients who showed mean maximum changes of -24% in forced one-second expiratory volume (FEV1) and 130% in airways resistance (Raw) following a single, 80 mg dose of propranolol." | 9.06 | Bronchosparing properties of celiprolol, a new beta 1, alpha 2-blocker, in propranolol-sensitive asthmatic patients. ( Applin, WJ; Braig, H; Doshan, HD; Matthys, H; Pohl, M; Rühle, KH, 1986) |
| "The effects of two cardioselective beta-adrenergic blocking agents--celiprolol (claimed to have bronchodilator properties) and atenolol (without such claims)--on respiratory function and control of asthma were studied in ten asthmatic patients with mild to moderate essential hypertension." | 9.06 | Comparison of respiratory effects of two cardioselective beta-blockers, celiprolol and atenolol, in asthmatics with mild to moderate hypertension. ( Bateman, ED; Jennings, AA; Opie, LH; van Zyl, AI, 1989) |
| "In 10 patients with bronchial asthma but normal ventilatory function, celiprolol, a cardioselective beta-adrenoreceptor antagonist, did not significantly affect forced expiratory volume in 1 second (FEV1) or airways resistance (Raw)." | 9.06 | Effects of celiprolol on the bronchial reactivity in asthma. ( Bruschi, C; Casali, L; Cerveri, I; Peona, V; Zoia, MC, 1988) |
| "Previous studies have shown that single dose or short-term administration of celiprolol does not impair pulmonary function in patients with asthma." | 9.06 | Effect of long-term treatment with celiprolol on pulmonary function in a group of mild hypertensive asthmatics. ( Clauzel, AM; Etienne, R; Jean, T; Michel, F; Visier, S, 1988) |
| "The respiratory effects of nebivolol, a new selective ss(1)-adrenergic blocking agent, and celiprolol, a ss-blocker possessing strong ss(1)-adrenoceptor antagonist and mild ss(2)-agonist properties, were investigated in 12 patients with mild asthma." | 7.70 | Comparison of the effects of single oral doses of nebivolol and celiprolol on airways in patients with mild asthma. ( Cazzola, M; D'Amato, G; D'Amato, M; Noschese, P, 2000) |
| " Therefore, 15 patients with bronchial asthma were given a single dose of 100 mg celiprolol (and 5 of them 300 mg) and airway obstruction (Raw, FEV1), pulse rate and blood pressure were documented for 3 hours." | 7.66 | [Effect of celiprolol, fenoterol and aminophylline on respiratory tract obstruction during an asthma attack]. ( Matthys, H, 1982) |
| " In two, randomized, placebo-controlled, 5-way crossover trials, the pulmonary effects of celiprolol 200 and 400 mg, propranolol 40 mg and atenolol 100 mg were compared in 34 asthmatic patients." | 5.06 | Celiprolol, atenolol and propranolol: a comparison of pulmonary effects in asthmatic patients. ( Applin, WJ; Brown, R; Caruso, FS; Doshan, HD; Rosenthal, RR; Slutsky, A, 1986) |
| "Sixteen normotensive asthmatic patients received single doses of 400 and 600 mg of celiprolol and 100 mg of atenolol in this placebo-controlled, double-blind crossover study." | 5.06 | Effects of high doses of celiprolol in asthmatic patients. ( Applin, WJ; Brown, R; Caruso, FS; Doshan, HD; Kapoor, M, 1986) |
| "The bronchopulmonary effects of celiprolol were studied in 12 male asthmatic patients who showed mean maximum changes of -24% in forced one-second expiratory volume (FEV1) and 130% in airways resistance (Raw) following a single, 80 mg dose of propranolol." | 5.06 | Bronchosparing properties of celiprolol, a new beta 1, alpha 2-blocker, in propranolol-sensitive asthmatic patients. ( Applin, WJ; Braig, H; Doshan, HD; Matthys, H; Pohl, M; Rühle, KH, 1986) |
| "The effects of two cardioselective beta-adrenergic blocking agents--celiprolol (claimed to have bronchodilator properties) and atenolol (without such claims)--on respiratory function and control of asthma were studied in ten asthmatic patients with mild to moderate essential hypertension." | 5.06 | Comparison of respiratory effects of two cardioselective beta-blockers, celiprolol and atenolol, in asthmatics with mild to moderate hypertension. ( Bateman, ED; Jennings, AA; Opie, LH; van Zyl, AI, 1989) |
| "In 10 patients with bronchial asthma but normal ventilatory function, celiprolol, a cardioselective beta-adrenoreceptor antagonist, did not significantly affect forced expiratory volume in 1 second (FEV1) or airways resistance (Raw)." | 5.06 | Effects of celiprolol on the bronchial reactivity in asthma. ( Bruschi, C; Casali, L; Cerveri, I; Peona, V; Zoia, MC, 1988) |
| "Previous studies have shown that single dose or short-term administration of celiprolol does not impair pulmonary function in patients with asthma." | 5.06 | Effect of long-term treatment with celiprolol on pulmonary function in a group of mild hypertensive asthmatics. ( Clauzel, AM; Etienne, R; Jean, T; Michel, F; Visier, S, 1988) |
| "The respiratory effects of nebivolol, a new selective ss(1)-adrenergic blocking agent, and celiprolol, a ss-blocker possessing strong ss(1)-adrenoceptor antagonist and mild ss(2)-agonist properties, were investigated in 12 patients with mild asthma." | 3.70 | Comparison of the effects of single oral doses of nebivolol and celiprolol on airways in patients with mild asthma. ( Cazzola, M; D'Amato, G; D'Amato, M; Noschese, P, 2000) |
| " Therefore, 15 patients with bronchial asthma were given a single dose of 100 mg celiprolol (and 5 of them 300 mg) and airway obstruction (Raw, FEV1), pulse rate and blood pressure were documented for 3 hours." | 3.66 | [Effect of celiprolol, fenoterol and aminophylline on respiratory tract obstruction during an asthma attack]. ( Matthys, H, 1982) |
| "Celiprolol was compared with chlorthalidone, an antihypertensive drug without known effect on bronchial tone." | 2.66 | A comparison of celiprolol and chlorthalidone in hypertensive patients with reversible bronchial obstruction. ( Capone, P; Clauzel, AM; Dorow, P; Mathieu, M; Mayol, R, 1986) |
| "Celiprolol was compared with chlorthalidone in a double-blind randomized placebo-controlled study of 30 hypertensive or anginal patients with reversible bronchial obstruction." | 2.66 | Celiprolol--review of airways studies. ( Dorow, P, 1988) |
| "Celiprolol has no influence on the adenylyl cyclase activity of the dog heart." | 2.37 | [Intrinsic sympathomimetic action and its special features as demonstrated by the beta-1-receptor blocker celiprolol]. ( Pittner, H, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (64.00) | 18.7374 |
| 1990's | 6 (24.00) | 18.2507 |
| 2000's | 3 (12.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matthys, H | 3 |
| Szmidt, M | 1 |
| Minc, P | 1 |
| Wasiak, W | 1 |
| Cazzola, M | 1 |
| Noschese, P | 1 |
| D'Amato, M | 1 |
| D'Amato, G | 1 |
| Salpeter, S | 2 |
| Ormiston, T | 2 |
| Salpeter, E | 2 |
| Thom, S | 1 |
| Hughes, A | 1 |
| Schachter, M | 1 |
| Sever, P | 1 |
| Dickinson, R | 1 |
| Horobin, J | 1 |
| Pujet, JC | 1 |
| Dubreuil, C | 1 |
| Fleury, B | 1 |
| Provendier, O | 1 |
| Abella, ML | 1 |
| Iagenskiĭ, AV | 1 |
| Barsukov, BP | 1 |
| Frishman, WH | 1 |
| Dorow, P | 3 |
| Clauzel, AM | 2 |
| Capone, P | 2 |
| Mayol, R | 2 |
| Mathieu, M | 2 |
| Doshan, HD | 4 |
| Rosenthal, RR | 2 |
| Brown, R | 2 |
| Slutsky, A | 1 |
| Applin, WJ | 4 |
| Caruso, FS | 3 |
| Kapoor, M | 1 |
| Rühle, KH | 2 |
| Braig, H | 2 |
| Pohl, M | 2 |
| Schindl, R | 1 |
| Würtz, J | 1 |
| Hoffmann, H | 1 |
| van Zyl, AI | 1 |
| Jennings, AA | 1 |
| Bateman, ED | 1 |
| Opie, LH | 1 |
| Pittner, H | 1 |
| Hitzenberger, G | 1 |
| Bruschi, C | 1 |
| Casali, L | 1 |
| Cerveri, I | 1 |
| Peona, V | 1 |
| Zoia, MC | 1 |
| Jean, T | 1 |
| Etienne, R | 1 |
| Visier, S | 1 |
| Michel, F | 1 |
5 reviews available for celiprolol and Asthma
| Article | Year |
|---|---|
Cardioselective beta-blocker use in patients with reversible airway disease.
Topics: Acebutolol; Adrenergic beta-Antagonists; Asthma; Celiprolol; Female; Forced Expiratory Volume; Human | 2001 |
Cardioselective beta-blockers for reversible airway disease.
Topics: Acebutolol; Adrenergic beta-Antagonists; Asthma; Celiprolol; Female; Forced Expiratory Volume; Human | 2002 |
[The third generation of b-blockers: new possibilities ].
Topics: Adrenergic beta-Antagonists; Asthma; Celiprolol; Hemodynamics; Humans; Hypertension; Lipoproteins, H | 1992 |
Clinical perspective on celiprolol: cardioprotective potential.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Asthma; Blood Pressure; Celiprolol; Coronary Disease; | 1991 |
[Intrinsic sympathomimetic action and its special features as demonstrated by the beta-1-receptor blocker celiprolol].
Topics: Adrenergic beta-Antagonists; Animals; Asthma; Blood Coagulation; Bronchi; Bronchial Spasm; Calcium C | 1985 |
12 trials available for celiprolol and Asthma
| Article | Year |
|---|---|
[Comparison of the influence of celiprolol, metoprolol and atenolol on pulmonary ventilation in patients with asthma].
Topics: Adrenergic beta-Antagonists; Adult; Area Under Curve; Asthma; Atenolol; Celiprolol; Female; Hemodyna | 1999 |
Effects of celiprolol, a cardioselective beta-blocker, on respiratory function in asthmatic patients.
Topics: Adrenergic beta-Antagonists; Adult; Asthma; Bisoprolol; Bronchoconstriction; Celiprolol; Double-Blin | 1992 |
A comparison of celiprolol and chlorthalidone in hypertensive patients with reversible bronchial obstruction.
Topics: Adrenergic beta-Antagonists; Asthma; Celiprolol; Chlorthalidone; Clinical Trials as Topic; Double-Bl | 1986 |
Celiprolol, atenolol and propranolol: a comparison of pulmonary effects in asthmatic patients.
Topics: Adrenergic beta-Antagonists; Asthma; Atenolol; Celiprolol; Forced Expiratory Volume; Humans; Hyperte | 1986 |
Effects of high doses of celiprolol in asthmatic patients.
Topics: Adult; Asthma; Atenolol; Bronchi; Celiprolol; Double-Blind Method; Forced Expiratory Volume; Humans; | 1986 |
Bronchosparing properties of celiprolol, a new beta 1, alpha 2-blocker, in propranolol-sensitive asthmatic patients.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Asthma; Celiprolol; Forced Expirat | 1986 |
The effect of the cardioselective beta blocker celiprolol on pulmonary function in asthmatic patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Airway Resistance; Asthma; Celiprolol; Female; Forced Expi | 1986 |
Comparison of respiratory effects of two cardioselective beta-blockers, celiprolol and atenolol, in asthmatics with mild to moderate hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Asthma; Atenolol; Blood Pressure; Celip | 1989 |
Effects of celiprolol on the bronchial reactivity in asthma.
Topics: Adrenergic beta-Antagonists; Adult; Airway Resistance; Asthma; Bronchi; Celiprolol; Clinical Trials | 1988 |
Celiprolol--review of airways studies.
Topics: Antihypertensive Agents; Asthma; Celiprolol; Chlorthalidone; Clinical Trials as Topic; Double-Blind | 1988 |
Effect of long-term treatment with celiprolol on pulmonary function in a group of mild hypertensive asthmatics.
Topics: Adult; Aged; Antihypertensive Agents; Asthma; Celiprolol; Chlorthalidone; Clinical Trials as Topic; | 1988 |
Bronchoneutral effects in hypertensive asthmatics--celiprolol versus chlorthalidone.
Topics: Antihypertensive Agents; Asthma; Celiprolol; Chlorthalidone; Clinical Trials as Topic; Double-Blind | 1988 |
8 other studies available for celiprolol and Asthma
| Article | Year |
|---|---|
[Effect of celiprolol, fenoterol and aminophylline on respiratory tract obstruction during an asthma attack].
Topics: Acute Disease; Adult; Airway Obstruction; Aminophylline; Asthma; Blood Pressure; Celiprolol; Ethanol | 1982 |
Comparison of the effects of single oral doses of nebivolol and celiprolol on airways in patients with mild asthma.
Topics: Administration, Oral; Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Antagonists | 2000 |
Celiprolol.
Topics: Antihypertensive Agents; Asthma; Celiprolol; Contraindications; Humans; Hypertension; Propanolamines | 1992 |
Celiprolol.
Topics: Antihypertensive Agents; Asthma; Celiprolol; Contraindications; Humans; Hypertension; Propanolamines | 1992 |
Celiprolol, clinical dosage, efficacy and safety in asthmatic and elderly patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Asthma; Celiprolol; Drug Evaluation; Humans; Hypertension; | 1985 |
The cardiopulmonary effects of celiprolol and propranolol in asymptomatic bronchial asthmatics.
Topics: Adrenergic beta-Antagonists; Asthma; Celiprolol; Hemodynamics; Humans; Propanolamines; Propranolol; | 1985 |
Celiprolol: an investigation of a new beta 1-, alpha 2-adrenoceptor antagonist in asthmatic patients.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Asthma; Celiprolol; Drug Evaluatio | 1985 |
A comparative study of celiprolol and chlorthalidone in hypertensive patients with reversible airways obstruction.
Topics: Adrenergic beta-Antagonists; Asthma; Celiprolol; Chlorthalidone; Drug Evaluation; Humans; Hypertensi | 1985 |